Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal.

Hims & Hers on Saturday reversed course on launching a $49 ​version of Novo Nordisk's Wegovy weight loss pill after the Food ...

Hims & Hers announced they are scrapping plans to sell a compounded version of the weight loss drug Wegovy after federal regulators vowed to take action against the telehealth provider. “Since ...

Hims & Hers sent a shockwave through the pharmaceutical industry on Thursday with its announcement of a weight-loss pill with a $49-a-month introductory price. Its shares ended down anyway. That ...

Novo Nordisk shares rebounded on Friday after comments from the head of the U.S. Food and Drug Administration (FDA) signaled ...

If compounded and generic GLP-1 drugs work as well as brand-name versions, they could fill a significant void by offering ...

RFK Jr. has stated leucovorin will help "large numbers of children who suffer from autism." Many experts are skeptical about that.

Novo Nordisk warns of steeper revenue decline as Hims & Hers unveils a cheaper Wegovy pill alternative, deepening investor concerns.

Hims & Hers Health said Saturday that it would no longer offer a compounded version of the popular weight-loss medicine Wegovy, following increased scrutiny from federal regulators. Hims announced on ...